This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignees: Jiangsu Kanion Pharmaceutical Co., Ltd., Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Qingming Guo: Innovator in Pharmaceutical Compounds
Introduction
Qingming Guo is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable crystal forms of compounds. His work is essential for enhancing the efficacy and stability of medicinal products.
Latest Patents
Qingming Guo holds a patent for a crystal form of a compound, specifically S-(−)-2,3-methylenedioxy-5,8,13,13a-tetrahydro-10,11-dimethoxy-6H-dibenzo[a, g]quinolizine. This invention discloses a crystal form A of the compound, which is characterized by an X-ray powder diffraction pattern that includes three or more 2θ values selected from a specific group. The crystal form A is notable for its high stability and low hygroscopicity, making it suitable for use in patent medicine.
Career Highlights
Qingming Guo is currently associated with Jiangsu Kanion Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative pharmaceutical solutions. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the industry.
Collaborations
Qingming Guo has collaborated with notable colleagues such as Wei Xiao and Wei Zhang. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical compounds.
Conclusion
Qingming Guo's contributions to the field of pharmaceuticals through his innovative patent work exemplify the importance of research and development in creating effective medicinal products. His achievements reflect a commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile